Cannabis Research - Peer-Reviewed Studies & Clinical Evidence

Cannabis Research

Peer-reviewed studies, clinical trials, and scientific evidence about cannabis. Evidence-based information for patients, healthcare providers, and advocates.

1,395 peer-reviewed studies
127 clinical trials
Updated weekly

Featured Research

High-impact studies that have shaped our understanding of cannabis medicine

Pain Management
2015

Cannabinoids for Medical Use: A Systematic Review and Meta-analysis

Whiting PF, Wolff RF, Deshpande S, et al.

JAMA2,847 citations

This systematic review examined 79 trials (6,462 participants) evaluating cannabinoids for various medical conditions. Evidence suggests cannabinoids are moderately effective for chronic pain and spasticity. Common adverse effects included dizziness, dry mouth, nausea, fatigue, somnolence, euphoria, vomiting, disorientation, drowsiness, confusion, loss of balance, and hallucination.

Key Findings:

  • Moderate-quality evidence supports use for chronic pain
  • High-quality evidence for chemotherapy-induced nausea
  • Moderate evidence for spasticity in multiple sclerosis
  • Limited evidence for other conditions
Pain Management
2018

Cannabis and Cannabinoids for the Treatment of People with Chronic Noncancer Pain Conditions

Stockings E, Campbell G, Hall WD, et al.

Cochrane Database of Systematic Reviews1,523 citations

This Cochrane review included 16 studies with 1,750 participants examining cannabis-based medicines for chronic noncancer pain. Authors found very low-quality evidence that cannabis-based medicines may increase the number of people achieving 50% pain relief, but also increase nervous system and psychiatric adverse events.

Key Findings:

  • Very low-quality evidence of pain reduction
  • Increased risk of short-term adverse events
  • No serious adverse events reported
  • More research needed on long-term effects
Neurology
2016

Cannabidiol in Patients with Treatment-Resistant Epilepsy: An Open-Label Interventional Trial

Devinsky O, Marsh E, Friedman D, et al.

The Lancet Neurology1,876 citations

This open-label trial examined cannabidiol (CBD) in 214 patients with treatment-resistant epilepsy. Median seizure frequency decreased from 30 per month at baseline to 15.8 per month during treatment. 9% of patients became seizure-free. Adverse events occurred in 79% of patients, most commonly somnolence, decreased appetite, and diarrhea.

Key Findings:

  • 47% reduction in median seizure frequency
  • 9% of patients became seizure-free
  • Well-tolerated in most patients
  • Supports further controlled trials

Browse by Category

Explore research organized by medical condition and application

Pain Management

Chronic pain, neuropathic pain, inflammatory conditions

342 studies

Mental Health

Anxiety, PTSD, depression, sleep disorders

287 studies

Neurology

Epilepsy, MS, Parkinson's, neuroprotection

198 studies

Oncology

Cancer pain, nausea, appetite, tumor effects

156 studies

Safety & Toxicology

Adverse effects, drug interactions, long-term safety

223 studies

Public Health

Policy, access, social impacts, epidemiology

189 studies

Recent Publications

Latest peer-reviewed research from 2023-2024

Review
2023

Medical Cannabis for Chronic Pain: A Clinical Review

Boehnke KF, Gagnier JJ, Matallana L, Williams DA

JAMA Network Open

Pain Management234 citations
Clinical Trial
2023

Cannabidiol for Treatment-Resistant Anxiety Disorders: A Randomized Trial

Shannon S, Lewis N, Lee H, Hughes S

The Permanente Journal

Mental Health412 citations
Longitudinal Study
2024

Long-term Safety of Medical Cannabis in Chronic Pain Patients

Haroutounian S, Ratz Y, Ginosar Y, et al.

European Journal of Pain

Safety & Toxicology156 citations
Meta-Analysis
2023

Cannabis Use and Opioid Reduction: A Systematic Review

Nielsen S, Sabioni P, Trigo JM, et al.

Addiction

Public Health389 citations
Review
2024

Neuroprotective Effects of Cannabidiol in Neurodegenerative Diseases

Fernández-Ruiz J, Sagredo O, Pazos MR, et al.

British Journal of Clinical Pharmacology

Neurology267 citations
Review
2023

Cannabis and Cancer: A Clinical Review of Therapeutic Applications

Abrams DI, Guzman M

Clinical Pharmacology & Therapeutics

Oncology198 citations

Ongoing Clinical Trials

Current research studies actively recruiting participants or in progress

Recruiting
Phase III

CBD for Treatment-Resistant Epilepsy in Children

NYU Langone Health
450 participants
Est. completion: December 2026
Active
Phase IV

Medical Cannabis vs. Opioids for Chronic Pain

University of Michigan
250 participants
Est. completion: June 2026
Recruiting
Phase II

Cannabinoids for PTSD in Veterans

VA San Diego Healthcare System
180 participants
Est. completion: March 2027
Active
Phase III

THC:CBD Ratios for Neuropathic Pain

McGill University
320 participants
Est. completion: September 2026

Stay Informed

Get weekly updates on new cannabis research, clinical trials, and scientific breakthroughs. Evidence-based information delivered to your inbox.